Health Headlines 10/21/06
About 700,000 People Each Year Seek Care In Emergency Departments For Adverse Supplement And Drug Reactions, Study Says ~> Click here.
FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression Treatment ~> Click here.
Lilly Launches Phase III 'GALES' Trial Of ALIMTA(R) (Pemetrexed For Injection) In Small Cell Lung Cancer ~> Click here.
Research Could Lead To Major Breakthrough In The Cost Of Effective New Cancer Drug ~> Click here.
Relaxin Expression By Adenovirus Improves Anticancer Activity ~> Click here.
Widely Prescribed Diabetes Drug Falls Short Of Promise, Says New Review ~> Click here.
New Alzheimer's Clinical Trials To Be Undertaken By NIA Nationwide Consortium, US ~> Click here.
FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression Treatment ~> Click here.
Lilly Launches Phase III 'GALES' Trial Of ALIMTA(R) (Pemetrexed For Injection) In Small Cell Lung Cancer ~> Click here.
Research Could Lead To Major Breakthrough In The Cost Of Effective New Cancer Drug ~> Click here.
Relaxin Expression By Adenovirus Improves Anticancer Activity ~> Click here.
Widely Prescribed Diabetes Drug Falls Short Of Promise, Says New Review ~> Click here.
New Alzheimer's Clinical Trials To Be Undertaken By NIA Nationwide Consortium, US ~> Click here.
posted by Kim @ 1:24 PM
0 Comments:
Post a Comment
<< Home